Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not

Anesthesiology

Volumn 111, Issue 1, 2009, Pages 102-109

  Alfonsi, Pascal ^a   Passard, Andrea ^a   Gaude joindreau, Valérie ^a   Guignard, Bruno ^a   Sessler, Daniel I ^b   Chauvin, Marcel ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; CLONIDINE; NEFOPAM;

ALERTNESS; ARTICLE; BRADYPNEA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; DIZZINESS; DRUG EFFICACY; DRUG POTENTIATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; INDUCED HYPOTHERMIA; INJECTION SITE PAIN; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; NORMAL HUMAN; OXYGEN CONSUMPTION; OXYGEN SATURATION; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SHIVERING; SHIVERING THRESHOLD; SIDE EFFECT; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; SWEATING; THERMOREGULATION; VASOCONSTRICTION; VOLUNTEER; VOMITING; XEROSTOMIA;

EID: 67650092011     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181a979c1     Document Type: Article

References (50)

1. Illievich UM, Zornow MH, Choi KT, Strnat MA, Scheller MS: Effects of hypothermia or anesthetics on hippocampal glutamate and glycine concentrations after repeated transient global cerebral ischemia. ANESTHESIOLOGY 1994;80:177-86
2. Kader A, Frazzini VI, Baker CJ, Solomon RA, Trifiletti RR: Effect of mild hypothermia on nitric oxide synthesis during focal cerebral ischemia. Neurosurgery 1994; 35:272-7
3. Group THACAS: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-56
4. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-63
5. ReithJ, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996; 347:422-5
6. Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS: Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke 2002; 33:1759-62
7. Schwab S, Schwarz S, SprangerM, Keller E, Bertram M, Hacke W: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998; 29:2461-6
8. De Georgia MA, Krieger DW, Abou-Chebl A, Devlin TG, Jauss M, Davis SM, Koroshetz WJ, Rordorf G, Warach S: Cooling for Acute Ischemic Brain Damage (COOL AID): A feasibility trial of endovascular cooling. Neurology 2004; 63:312-7
9. Zweifler RM, Sessler DI: Thermoregulatory vasococonstriction and shivering impede therapeutic hypothermia in acute ischemic stroke patients. J Stroke Cerebrovasc Dis 1996; 6:100-3
10. Kurz A, Sessler DI, Narzt E, Bekar A, Lenhardt R, Huemer G, Lackner F:Postoperative hemodynamic and thermoregulatory consequences of intraopera- tive core hypothermia. J Clin Anesth 1995; 7:359-66
11. Frank SM, el-Gamal N, Raja SN, Wu PK: Alpha-adrenoceptor mechanisms of thermoregulation during cold challenge in humans. Clin Sci (Lond) 1996; 91:627-31
12. Frank SM, Higgins MS, Breslow MJ, Fleisher LA, Gorman RB, Sitzmann JV, Raff H, Beattie C: The catecholamine, cortisol, and hemodynamic responses to mild perioperative hypothermia. A randomized clinical trial. ANESTHESIOLOGY 1995;82:83-93
13. Matsukawa T, Kurz A, Sessler DI, Bjorksten AR, Merrifield B, Cheng C:Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthe siology 1995; 82:1169-80
14. Annadata R, Sessler DI, Tayefeh F, Kurz A, Dechert M: Desflurane slightly increases the sweating threshold but produces marked, nonlinear decreases in the vasoconstriction and shivering thresholds. ANESTHESIOLOGY 1995; 83:1205-11
15. Kurz A, Go JC, Sessler DI, Kaer K, Larson MD, Bjorksten AR: Alfentanil slightly increases the sweating threshold and markedly reduces the vasoconstriction and shivering thresholds. ANESTHESIOLOGY 1995; 83:293-9
16. Kurz A, Xiong J, Sessler DI, Plattner O, Christensen R, Dechert M, Ikeda T:Isoflurane produces marked and nonlinear decreases in the vasoconstriction and shivering thresholds. Ann N Y Acad Sci 1997; 813:778-85
17. Doufas AG, Lin CM, SulemanMI, Liem EB, Lenhardt R, MoriokaN, Akca O, Shah YM, Bjorksten AR, Sessler DI: Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke 2003; 34:1218-23
18. Mokhtarani M, Mahgoub AN, Morioka N, Doufas AG, Dae M, Shaughnessy TE, Bjorksten AR, Sessler DI: Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg 2001; 93:1233-9
19. Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS: Nefopam: A review of its pharmacological properties and therapeutic efficacy. Drugs 1980;19:249-67
20. Guirimand F, Dupont X, Bouhassira D, Brasseur L, Chauvin M: Nefopam strongly depresses the nociceptive flexion (R(III)) reflex in humans. Pain 1999;80:399-404
21. Alfonsi P, Adam F, Passard A, Guignard B, Sessler DI, Chauvin M: Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects. ANESTHESIOLOGY 2004; 100:37-43
22. Girard P, Coppe MC, Verniers D, Pansart Y, Gillardin JM: Role of cat- echolamines and serotonin receptor subtypes in nefopam-induced antinocicetion. Pharmacol Res 2006; 54:195-202
23. Fernandez-Sanchez MT, Diaz-Trelles R, Groppetti A, Manfredi B, Brini AT,Biella G, Sotgiu ML, Novelli A: Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity. Amino Acids 2002; 23:31-6
24. De Witte J, Sessler DI: Perioperative shivering: Physiology and pharmacology. ANESTHESIOLOGY 2002; 96:467-84
25. Bhatt AM, Pleuvry BJ, Maddison SE: Respiratory and metabolic effects of oral nefopam in human volunteers. Br J Clin Pharmacol 1981; 11:209-11
26. Beloeil H, Eurin M, Thevenin A, Benhamou D, Mazoit JX: Effective dose of nefopam in 80% of patients (ED80): A study using the continual reassessment method. Br J Clin Pharmacol 2007; 64:686-93
27. Piercy DM, Cumming JA, Dawling S, Henry JA: Death due to overdose of nefopam. BMJ (Clin Res Ed) 1981; 283:1508-9
28. Tracqui A, Berthelon L, Ludes B: Fatal overdosage with nefopam (Acupan).J Anal Toxicol 2002; 26:239-43
29. Urwin SC, Smith HS: Fatal nefopam overdose. Br JAnaesth 1999; 83:501-2
30. Delaunay L, Bonnet F, Liu N, Beydon L, Catoire P, Sessler DI: Clonidine comparably decreases the thermoregulatory thresholds for vasoconstriction and shivering in humans. ANESTHESIOLOGY 1993; 79:470-4
31. Mather GG, Labroo R, Le Guern ME, Lepage F, Gillardin JM, Levy RH: Nefopam enantiomers: Preclinical pharmacology/toxicology and pharmacoki-netic characteristics in healthy subjects after intravenous administration. Chiral-ity 2000; 12:153-9
32. Frisk-Holmberg M, Edlund PO, Paalzow L: Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Br J Clin Pharmacol 1978;6:227-32
33. Joris J, Banache M, Bonnet F, Sessler DI, LamyM: Clonidine and ketanserin both are effective treatment for postanesthetic shivering. ANESTHESIOLOGY 1993;79:532-9
34. Lund C, BrowderN: The estimation of areas of burns. Surg Gynecol Obstet 1944; 79:352-8
35. Rubinstein EH, Sessler DI: Skin-surface temperature gradients correlate with fingertip blood flow in humans. ANESTHESIOLOGY 1990; 73:541-5
36. Kurz A, Sessler DI, Christensen R, Dechert M: Heat balance and distribution during the core-temperature plateau in anesthetized humans. ANESTHESIOLOGY1995; 83:491-9
37. Slinker BK: The statistics of synergism. J Mol Cell Cardiol 1998; 30:723-31
38. Kammersgaard LP, Rasmussen BH, Jorgensen HS, Reith J, Weber U, Olsen TS: Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: A case-control study: The Copenhagen Stroke Study. Stroke 2000; 31:2251-6
39. Alfonsi P, Nourredine KE, Adam F, Chauvin M, Sessler DI: Effect of postoperative skin-surface warming on oxygen consumption and the shivering threshold. Anaesthesia 2003; 58:1228-34
40. KurzA, PlattnerO, Sessler DI, Huemer G, Redl G, LacknerF: The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in elderly than in young patients. ANESTHESIOLOGY 1993; 79:465-9
41. Vassilieff N, Rosencher N, Sessler DI, Conseiller C: Shivering threshold during spinal anesthesia is reduced in elderly patients. ANESTHESIOLOGY 1995;83:1162-6
42. Frank SM, Raja SN, Bulcao CF, Goldstein DS: Relative contribution of core and cutaneous temperatures to thermal comfort and autonomic responses in humans. J Appl Physiol 1999; 86:1588-93
43. Kimberger O, Ali SZ, Markstaller M, Zmoos S, Lauber R, Hunkeler C, Kurz A: Meperidine and skin surface warming additively reduce the shivering threshold: A volunteer study. Crit Care 2007; 11:R29
44. Kurz A, Ikeda T, Sessler DI, Larson MD, Bjorksten AR, Dechert M, Christensen R: Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. ANESTHESIOLOGY 1997; 86:1046-54
45. Zweifler RM, Voorhees ME, Mahmood MA, Parnell M: Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke 2004; 35:2331-4
46. Koe BK: Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 1976; 199:649-61
47. Khan ZP, Ferguson CN, Jones RM: Alpha-2 and imidazoline receptor agonists. Their pharmacologyand therapeutic role. Anaesthesia 1999; 54:146-65
48. Gray AM, Nevinson MJ, Sewell RD: The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception. Eur J Pharmacol 1999; 365:149-57
49. Durrieu G, Olivier P, Bagheri H, Montastruc JL: Overview of adverse reactions to nefopam: An analysis of the French Pharmacovigilance database. Fundam Clin Pharmacol 2007; 21:555-8
50. Pillans PI, Woods DJ: Adverse reactions associated with nefopam.NZMed J 1995; 108:382-4